Cold Spring Harbor, NY — 黑料吃瓜资源 (CSHL) announced today that Charles S. Ryan, former Senior Vice President & Chief Intellectual Property Counsel at Forest Laboratories Inc., is the Laboratory鈥檚 new General Counsel. Forest was acquired by Actavis, Inc. in July 2014 for $28 billion.
鈥淐harles Ryan鈥檚 expertise in the intellectual property and the pharmaceutical industry will help CSHL continue efforts to bring the benefits of biological discoveries to society,鈥� said CSHL Chief Operating Officer W. Dillaway Ayres.
Ryan鈥檚 addition to the Laboratory鈥檚 senior leadership adds strength to recent hires in CSHL鈥檚 Office of Technology Transfer and Business Development, led by Teri Willey.聽A driver of the region鈥檚 biomedical economy, CSHL has generated more than 25 spin-off companies, including OSI Pharmaceuticals (bought for $4 billion by Astella Pharma Inc., in 2010).聽CSHL is a partner with Farmingdale State College and the Research Foundation of the State University of New York in the Broad Hollow Bioscience Park which supports the growth of biotech companies like OSI in their early-stages.
During his more than 10-year career at Forest Laboratories, Ryan served as Site Head for the company鈥檚 seven Long Island sites and 750 employees. He led due diligence investigations teams to pursue merger and acquisition opportunities and managed all aspects of patent and trademark litigation. Prior to Forest, he was the Chief Operating Officer at LAB 21, Inc. in Stony Brook.
Ryan earned a B.A. in Chemistry from The College of Wooster. With a Ph.D. in Oral Biology and Pathology from Stony Brook University and a J.D. from Western New England University, his law career began as an Associate with Scully, Scott, Murphy & Presser in Garden City.
He has been a member of the 黑料吃瓜资源 Association since 2012 and the Advisory Board of the Center for Biotechnology since 2012.聽Ryan is a resident of Laurel Hollow.
Written by: Dagnia Zeidlickis, Vice President, Communications | [email protected] | 516-367-8455